An Act To Facilitate Access to Naloxone Hydrochloride
Sec. 1. 22 MRSA §2353, sub-§1, ¶D is enacted to read:
Sec. 2. 22 MRSA §2353, sub-§2, as amended by PL 2015, c. 351, §1, is further amended to read:
Nothing in this subsection affects the provisions of law relating to maintaining the confidentiality of medical records.
Sec. 3. 22 MRSA §2353, sub-§3, as enacted by PL 2013, c. 579, §1, is amended to read:
Sec. 4. 22 MRSA §2353, sub-§5 is enacted to read:
Sec. 5. 32 MRSA c. 117, sub-c. 11-A is enacted to read:
DISPENSING OF NALOXONE HYDROCHLORIDE
§ 13815. Authorization
The board by rule shall establish procedures and standards for authorizing pharmacists to dispense naloxone hydrochloride. The rules must establish adequate training requirements and protocols for dispensing naloxone hydrochloride by prescription drug order or standing order or pursuant to a collaborative practice agreement. Rules adopted under this section are routine technical rules as defined in Title 5, chapter 375, subchapter 2-A. A pharmacist authorized by the board pursuant to this section to dispense naloxone hydrochloride may dispense naloxone hydrochloride in accordance with Title 22, section 2353.
Sec. 6. Adoption of rules. The Maine Board of Pharmacy shall adopt rules pursuant to the Maine Revised Statutes, Title 32, section 13815 no later than July 1, 2017.